| Detailed Quote for DARA Biosciences Inc. (DARA) |
|
|
|
|
close
52 Week Information
52 Week High
 September 16,2009
Close:
12.6272
52 Week Low
 August 26,2010
Close:
2.07
|
|
|
|
|
| Change $ |
|---|
0.07
|
|
| Change % |
|---|
3.02%
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
close
Exchange Information
Listed On
Nasdaq Small Caps (NSC)
Exchange |
|---|
NSC |
|
|
|
|
|
News and Media for DARA Biosciences Inc.
(DARA)
|
|
|
News for DARA
|
|
|
|
| 8:45 AM |
DARA BioSciences to Present at Rodman & Renshaw Annual Global Investment Conference - Globe Newswire |
|
|
|
| 8:45 AM |
DARA BioSciences Selected to Present at the 13th World Congress on Pain - Globe Newswire |
|
|
|
| 2:38 PM |
DARA BioSciences, Inc. Announces it is Indefinitely Suspending Its Public Unit Offering - Globe Newswire |
|
|
|
| 1:10 PM |
PennyOmega.com Announces Stock Alert on DARA, ORFG, MNKD, SNRY - World Stock Wire |
|
|
|
| 4:31 PM |
DARA BioSciences Reports on SurgiVision Receiving FDA Clearance to Market Its ClearPoint System - Globe Newswire |
|
|
|
| 9:30 AM |
DARA BioSciences to Present at Sidoti & Company 2010 Semiannual Micro-Cap Conference and OneMedForum 2010 New York Conference - Globe Newswire |
|
|
|
| 10:25 AM |
DARA Regains NASDAQ Minimum Bid Price Compliance - Globe Newswire |
|
|
|
| 8:45 AM |
DARA BioSciences to Raise Up to $10,000,000 Through Public Offering - Globe Newswire |
|
|
|
| 5:01 PM |
DARA BioSciences, Inc. Announces Results of Annual Meeting and Implementation of a 16-for-1 Reverse Stock Split - Globe Newswire |
|
|
|
| 10:02 AM |
DARA BioSciences Enters Into a Clinical Trial Collaboration With the Division of Cancer Prevention (DCP), National Cancer Institute (NCI) for the Clinical Development of KRN5500 - Globe Newswire |
|
|
|
| 10:18 AM |
DARA BioSciences to Present Results of a Phase 2 Clinical Study for KRN5500 at the "Third International Congress on Neuropathic Pain" - Globe Newswire |
|
|
|
| 10:01 AM |
DARA BioSciences Initiates a Phase I Clinical Study of DB959 for the Treatment of Type 2 Diabetes - Globe Newswire |
|
|
|
| 5:00 PM |
DARA Receives Anticipated Notice of Non-Compliance From NASDAQ - Globe Newswire |
|
|
|
| 9:16 AM |
DARA BioSciences Closes at Market Private Placement Transaction - Globe Newswire |
|
|
|
| 10:23 AM |
DARA BioSciences to Present Results of a Clinical Study for KRN5500 at the "Annual Targeting Pain with Novel Therapeutics" Meeting Sponsored by Cambridge Healthtech Institute - Globe Newswire |
|
|
|
| 9:25 AM |
Skymark Research Initiates Independent Research Coverage on DARA BioSciences, Inc. - Globe Newswire |
| 6:52 AM |
Biotech Stock Alert for DARA BioSciences Inc. Issued by StockPreacher - Globe Newswire |
|
|
|
| 8:31 AM |
C. K. Cooper & Company Initiates Coverage of DARA BioSciences, Inc. - Globe Newswire |
|
|
|
| 1:34 PM |
DARA BioSciences to Present at Sidoti & Company 2010 Micro Cap Conference and OneMedForum 2010 Emerging Company Finance Conference - Globe Newswire |
|
|
|
| 11:46 AM |
DARA BioSciences Reports on SurgiVision's Filing of a Registration Statement With the Securities and Exchange Commission for an Initial Public Offering (IPO) - Globe Newswire |
|
More News for DARA >> |
|
|
